Cite
Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
MLA
Perraut, Ronald, et al. “Association of Antibodies to Plasmodium Falciparum Merozoite Surface Protein-4 with Protection against Clinical Malaria.” Vaccine, vol. 35, no. 48B, Dec. 2017, pp. 6720–26. EBSCOhost, https://doi.org/10.1016/j.vaccine.2017.10.012.
APA
Perraut, R., Varela, M.-L., Joos, C., Diouf, B., Sokhna, C., Mbengue, B., Tall, A., Loucoubar, C., Touré, A., & Mercereau-Puijalon, O. (2017). Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Vaccine, 35(48B), 6720–6726. https://doi.org/10.1016/j.vaccine.2017.10.012
Chicago
Perraut, Ronald, Marie-Louise Varela, Charlotte Joos, Babacar Diouf, Cheikh Sokhna, Babacar Mbengue, Adama Tall, Cheikh Loucoubar, Aissatou Touré, and Odile Mercereau-Puijalon. 2017. “Association of Antibodies to Plasmodium Falciparum Merozoite Surface Protein-4 with Protection against Clinical Malaria.” Vaccine 35 (48B): 6720–26. doi:10.1016/j.vaccine.2017.10.012.